Key facts
- It has raised $2.8M; the latest was Early Stage VC in Oct 2025.
- Notable investors include Hunan Lushan Technology Investment, Hunan Chasing Fund, Changsha Chang Xin Investment Management, Changsha Science & Technology Venture Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Maikenwei
- ·The full record, as it builds
Funding rounds
No funding rounds for Maikenwei are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Maikenwei
Developer of bio-catalysis designed for synthetic microbiology. The company offers agriculture, medicine, mining and provender bio-catalyst, thereby enabling clients with environmentally friendly and innovative bio-catalysis.
- Sector
- Healthcare
- HQ
- Changsha, China
- Founded
- 2023
- Employees
- 67
- Website
- mcwbio.com/
- Ownership
- Privately Held (backing)
Maikenwei doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Maikenwei shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Maikenwei in its N-PORT filings yet. We sweep new filings monthly.